Article Text

Download PDFPDF

Forming the initial European Statements of Hospital Pharmacy
  1. Aida Batista1,
  2. David Preece2
  1. 1Department of Pharmacy, Centro Hospitalar de Vila Nova de Gaia/Espinho, EPE, Vila Nova de Gaia, Portugal
  2. 2Department of Policy and Advocacy, The European Association of Hospital Pharmacists, Brussels, Belgium
  1. Correspondence to Dr Aida Batista, Department of Pharmacy, Centro Hospitalar de Vila Nova de Gaia/Espinho, EPE, Rua Conceição Fernandes, Vila Nova de Gaia 4434-502, Portugal; aida.batista{at}

Statistics from


In anticipation of the European Summit on Hospital Pharmacy preliminary work was required. This article intends to describe the whole process of choosing the basis of the work, the discussions and construction of statements that would be introduced to the Delphi process with the objective of determining which statements would be voted on at the Summit by hospital pharmacists, patient representatives and healthcare professionals.

Mission and goals of Working Group 2

For the task of preparing a version of statements that would be subject to the Delphi process, intended to be one of the building stages of European statements, it was decided to create a working group, which was called the Working Group 2 (WG2), assisting the other groups to prepare the Summit.

The mission of WG2 was to review the International Pharmaceutical Federation (FIP)’s 2008 Basel Statements of Hospital Pharmacy Practice1 with a view to their applicability in the European context.

The Basel Statements would have to be identified and revised according to their relevance and meaning for the future of European hospital pharmacists and also according to their importance and impact on patient outcomes. In the translation of the meaning of statements, the group should always bear in mind the following questions:

  • What hospital pharmacists do

  • Why they do it

  • Who they do it with (patients, doctors, nurses)

  • How they will do it.

The expected result of the work and consequently of the Summit itself would be a pathway to achieve the best possible practice in Europe, always seeking the best outcomes and improved patient safety. As a result, it was intended to increase and improve the trust among hospital pharmacists, patients and all stakeholders.

First operations

The work began at a meeting of a small group invited by the Board of the European Association of Hospital Pharmacists (EAHP) and held in September 2012.

During the …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.